OTCMKTS:GBCS Selectis Health (GBCS) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free GBCS Stock Alerts $2.00 0.00 (0.00%) (As of 04/26/2024 01:06 PM ET) Add Compare Share Share Today's Range$2.00▼$2.0050-Day Range$1.30▼$3.5052-Week Range$1.05▼$6.25Volume2,000 shsAverage Volume1,905 shsMarket Capitalization$6.13 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsStock AnalysisChartEarningsFinancialsHeadlinesSEC Filings Get Selectis Health alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About Selectis Health Stock (OTCMKTS:GBCS)Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents. With its focused growth strategy, Selectis intends to deepen its American Southcentral and Southeastern market presence to better serve the aging population along a full continuum of care.Read More GBCS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GBCS Stock News HeadlinesApril 24, 2024 | forbes.comBest Electric Wheelchairs Of 2024April 9, 2024 | forbes.comBest Hearing Aids Of 2024April 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.April 1, 2024 | finance.yahoo.comSelectis Health, Inc. (GBCS)February 20, 2024 | forbes.comSoutheast HealthFebruary 13, 2024 | forbes.comInfirmary HealthDecember 19, 2023 | msn.comSelectis Health appoints Jim Creamer as interim finance chiefDecember 5, 2023 | msn.comSelectis Health to sell four skilled nursing facilities in Georgia for $31MApril 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.December 5, 2023 | finance.yahoo.comSelectis Health Enters Agreements to Sell Four Skilled Nursing Facilities in GeorgiaOctober 29, 2023 | dailymail.co.ukWhy going to church is healthySeptember 28, 2023 | bbc.comNHS Wales: Health board deficits could hit £800mSeptember 6, 2023 | forbes.com10 Best Mobility Scooters Of 2023August 29, 2023 | forbes.com5 Best Stair Lifts Of 2023: Reviews And ComparisonsAugust 25, 2023 | forbes.comBest Dating Sites Of 2023: Reviews And CostsAugust 4, 2023 | health.usnews.comUP Health System-BellJuly 22, 2023 | health.usnews.comTerrebonne General Health System-HoumaJuly 14, 2023 | forbes.comBest Melatonin Supplements Of 2023, According To ExpertsJune 13, 2023 | forbes.com5 Science-Backed Health Benefits Of TurmericMay 31, 2023 | cnbc.comHow the end of the Covid-19 public health emergency could affect your walletMay 19, 2023 | forbes.comBest Weight Loss Programs Of 2023, According To ExpertsMay 18, 2023 | forbes.comTypes of Hearing Aids: How To Choose The Right OneMay 9, 2023 | forbes.comBest Online Pharmacies Of May 2023May 5, 2023 | forbes.comNoom Diet Review 2023: Costs, Benefits And DrawbacksMay 3, 2023 | forbes.comBest Online Dating Sites Of 2023April 27, 2023 | forbes.comThe Best Bug Sprays For 2023April 27, 2023 | forbes.comBest Online Marriage Counseling Of 2023See More Headlines Receive GBCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Selectis Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/20/2017Today4/27/2024Next Earnings (Estimated)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Real estate investment trusts Sub-IndustryN/A Current SymbolOTCMKTS:GBCS CUSIPN/A CIK727346 Webwww.gbcsreit.com Phone(720) 680-0808Fax303-527-2916Employees671Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.30) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,970,000.00 Net Margins-10.82% Pretax Margin-10.80% Return on Equity-651.76% Return on Assets-8.91% Debt Debt-to-Equity RatioN/A Current Ratio0.27 Quick Ratio0.27 Sales & Book Value Annual Sales$36.78 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($1.22) per share Price / Book-1.64Miscellaneous Outstanding SharesN/AFree FloatN/AMarket Cap$6.13 million OptionableNot Optionable Beta-0.36 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Adam Desmond (Age 53)Interim CEO & Director Comp: $30kMr. Clifford L. Neuman (Age 76)Director & Legal Counsel Comp: $22.5kMs. Christine Lucus (Age 34)Company Secretary Comp: $138.89kMr. James W. Creamer III (Age 59)Interim Chief Financial Officer Ms. Sarah DayDirector of Therapy, Marketing & StaffingKey CompetitorsVaccinexNASDAQ:VCNXCV SciencesOTCMKTS:CVSIChromocell TherapeuticsNYSE:CHROHealthcare TriangleNASDAQ:HCTIGuided TherapeuticsOTCMKTS:GTHPView All Competitors GBCS Stock Analysis - Frequently Asked Questions How have GBCS shares performed in 2024? Selectis Health's stock was trading at $4.30 at the start of the year. Since then, GBCS stock has decreased by 53.5% and is now trading at $2.00. View the best growth stocks for 2024 here. When is Selectis Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our GBCS earnings forecast. How were Selectis Health's earnings last quarter? Selectis Health, Inc. (OTCMKTS:GBCS) posted its quarterly earnings data on Monday, November, 20th. The company reported ($0.20) earnings per share (EPS) for the quarter. The company had revenue of $0.75 million for the quarter. Selectis Health had a negative trailing twelve-month return on equity of 651.76% and a negative net margin of 10.82%. When did Selectis Health's stock split? Shares of Selectis Health reverse split on the morning of Wednesday, September 22nd 2021. The 1-10 reverse split was announced on Wednesday, September 22nd 2021. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, September 22nd 2021. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of Selectis Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Selectis Health investors own include Chemed (CHE), Walt Disney (DIS), OceanFirst Financial (OCFC), Celanese (CE), Credit Acceptance (CACC), Blackstone Mortgage Trust (BXMT), Blackstone (BX), Black Hills (BKH), Sothebys (BID) and Basf (BASFY). How do I buy shares of Selectis Health? Shares of GBCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:GBCS) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Selectis Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
